Φορτώνει......
Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies
Following the clinical success of cancer immunotherapies such as immune checkpoint inhibitors blocking B7/CTLA-4 or PD-1/PD-L1 signaling and ongoing numerous combination therapies in the clinic,3 bispecific antibodies (BsAbs) are now emerging as a growing class of immunotherapies with the potential...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Vaccines (Basel) |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
MDPI
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8310217/ https://ncbi.nlm.nih.gov/pubmed/34358141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9070724 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|